Current practice on covariate adjustment and stratified analysis —based on survey results by ASA oncology estimand working group conditional and marginal effect task force
Abstract Background The 2023 FDA's guidance on covariate adjustment encourages the judicious use of baseline covariates to enhance efficiency. However, when performing covariate adjustment in non-linear models, care must be taken on preserving estimation of the target estimand as introduced by the I...
محفوظ في:
| المؤلفون الرئيسيون: | , , , , , , , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
BMC
2025-11-01
|
| سلاسل: | BMC Medical Research Methodology |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://doi.org/10.1186/s12874-025-02670-7 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
